Literature DB >> 10954672

Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine.

D Marcoux1, R Anex, P Russo.   

Abstract

A 15-year-old boy experienced a macular serpentine erythematous eruption that subsided with a persistent hyperpigmentation overlying the superficial venous network of the left forearm. This reaction occurred at the injection site of a chemotherapy regimen that combined actinomycin and vincristine a few hours after the first course. After a single injection of actinomycin in the right arm, a similar reaction occurred, implicating it as the responsible agent. A skin biopsy specimen demonstrated a cell-poor interface tissue reaction associated with an eccrine neutrophilic hidradenitis. To our knowledge, this is the first case of persistent supravenous serpentine hyperpigmented eruption reported in a child treated with this particular drug combination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954672     DOI: 10.1067/mjd.2000.106239

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance Revisited.

Authors:  Elisa Ríos-Viñuela; Eduardo Bernia; Tomás Toledo-Pastrana; Celia Requena; Adrián Diago; Carlos Serra-Guillén; Beatriz Llombart; Victor Traves; Eduardo Nagore; Carlos Guillén; Onofre Sanmartin
Journal:  Acta Derm Venereol       Date:  2021-04-12       Impact factor: 3.875

2.  Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL.

Authors:  Guido Lancman; Amir Steinberg; Janice Gabrilove
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2018-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.